About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
SOHO Italy
www.sohoitaly.it
5th SOHO Italy Annual Conference
Leukemia
Lymphoma
Myeloma
MDS & MPN
CAR-T and Benign Hematology
Videos
SOHO 4th Italian Conference
Leukemia
Lymphoma
Myeloma
MDS and MPN
CAR-T and Benign Hematology
2nd School of Multiple Myeloma
SOHO Italy 1st Clinical and Biological School of CAR-T
SOHO 3rd Italian Conference
1st School of Acute Leukemia
Extracellular Vesicles and Their Role in Patients With Multiple Myeloma
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
CAR-T Based Approach in ALL: Humanized CAR-T, Fast-Off Rate Low-Affinity CAR-T 19, CAR-T 22, Dual CAR-T, CAR-T for T-ALL & NK-CAR
By
SOHO Italy 1st School of Acute Leukemia
FEATURING
Josep-Maria Ribera
By
SOHO Italy 1st School of Acute Leukemia
FEATURING
Josep-Maria Ribera
16 views
April 14, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
23:35
University of Colorado Division of Hematology
2024 Updates in PV/ET
Feat.
B. McMahon
Featured Video
08:18
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…
Feat.
A. Zhou
1st School of Acute Leukemia
13:35
SOHO Italy 1st School of Acute Leukemia
The Road to AML: A Clinical and Biological Overview
Feat.
S. Galimberti
07:52
SOHO Italy 1st School of Acute Leukemia
AML Molecular Pathogenesis & Approach to Therapeutic Targets
Feat.
S. Galimberti
10:49
SOHO Italy 1st School of Acute Leukemia
FLT3m AML: Midostaurin + Chemo, Sorafenib Maintenance After Allo-HSC…
Feat.
G. Martinelli
25:10
SOHO Italy 1st School of Acute Leukemia
AML in 2021: MD Anderson Perspective on Progress in Research and The…
Feat.
H. Kantarjian
20:05
SOHO Italy 1st School of Acute Leukemia
Optimizing FLT3i Use in FLT3+ AML in 2021: What Are the Current and …
Feat.
N. Daver
15:43
SOHO Italy 1st School of Acute Leukemia
2021 AML Drugs in EU: Microenvironment & Parasite Relations, Pot…
Feat.
G. Martinelli
16:03
SOHO Italy 1st School of Acute Leukemia
2021 Updates on the Role of Maintenance in AML: Stem Cell Modeling, …
Feat.
M. Gottardi
15:53
SOHO Italy 1st School of Acute Leukemia
Role of SCT in AML: Choice of Donor, HSCT in Active Disease, Older P…
Feat.
A. Olivieri
14:48
SOHO Italy 1st School of Acute Leukemia
Environment-Mediated Drug Resistance in AML: Is Targeting CAMDR a Ne…
Feat.
C. Cerchione
09:40
SOHO Italy 1st School of Acute Leukemia
Role of Single Agent IDHi in AML: Effects on Hematopoiesis, Ena/Ivo …
Feat.
M. Paola Martelli
05:02
SOHO Italy 1st School of Acute Leukemia
IDH1/2 Inhibitor Combinations for AML: Ivo/Ena+Aza for Newly Diagnos…
Feat.
M. Paola Martelli
14:25
SOHO Italy 1st School of Acute Leukemia
2021 Updates on Ph+ ALL: Chemo+Dasatinib, Dasatinib vs. Imatinib in …
Feat.
E. Jabbour
12:15
SOHO Italy 1st School of Acute Leukemia
Integrating IO in the Frontline ALL: Hyper-CVAD+Ponatinib, Blina+Ino…
Feat.
E. Jabbour
16:56
SOHO Italy 1st School of Acute Leukemia
Novel Antibodies in AML: What Is the Role of Gemtuzumab Ozogamicin? …
Feat.
F. Ravandi
16:41
SOHO Italy 1st School of Acute Leukemia
AML Management: Strategies to Integrate IO & Targeted Therapies
Feat.
N. Daver
13:23
SOHO Italy 1st School of Acute Leukemia
CAR-T Based Approach in ALL: Humanized CAR-T, Fast-Off Rate Low-Affi…
Feat.
J. Ribera
07:44
SOHO Italy 1st School of Acute Leukemia
How Do I Manage Ph-Like ALL at MD Anderson: HCVAD + Ofatumumab, Test…
Feat.
M. Konopleva
05:05
SOHO Italy 1st School of Acute Leukemia
How Do I Manage ETP ALL at MD Anderson: Hyper-CVAD + Nelarabine, Hyp…
Feat.
M. Konopleva
24:35
SOHO Italy 1st School of Acute Leukemia
CD19 Cells in Childhood & Adult ALL Relapsed After ASCT: Anti-CD…
Feat.
A. Rambaldi
20:15
SOHO Italy 1st School of Acute Leukemia
Role of mAbs in R/R ALL: INO vs. SoC, INO for B-Cell Disease Eligibl…
Feat.
F. Lanza
14:08
SOHO Italy 1st School of Acute Leukemia
2021 ALL Updates: Disease Identification Markers, INO vs. SoC in R/R…
Feat.
G. Martinelli
21:41
SOHO Italy 1st School of Acute Leukemia
2021 Updates on MRD Assessment and Impact on AML: MRD Monitoring, EL…
Feat.
F. Buccisano
19:42
SOHO Italy 1st School of Acute Leukemia
How I Manage ALL in 2021: Can Adult Ph+ Patients Achieve CMR With Da…
Feat.
G. Martinelli
26:39
SOHO Italy 1st School of Acute Leukemia
2021 MD Anderson Updates on ALL: Treatment Comparison by Age and Dis…
Feat.
H. Kantarjian
